Nuveen’s United Therapeutics UTHR Stock Holding History

Nuveen’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$113M	Sell	190,697 -61,112	-24%	-$30.4M	0.03%	366
2025 Q4	$123M	Sell	251,809 -35,258	-12%	-$16.4M	0.03%	347
2025 Q3	$120M	Buy	287,067 +35,768	+14%	+$12M	0.03%	367
2025 Q2	$72.2M	Sell	251,299 -19,676	-7%	-$5.88M	0.02%	482
2025 Q1	$83.5M	Sell	270,975 -60,700	-18%	-$20.8M	0.03%	449
2024 Q4	$117M	Sell	331,675 -27,888	-8%	-$10.3M	0.03%	365
2024 Q3	$129M	Sell	359,563 -74,951	-17%	-$25.3M	0.04%	360
2024 Q2	$138M	Sell	434,514 -30,360	-7%	-$8.04M	0.04%	330
2024 Q1	$107M	Sell	464,874 -26,631	-5%	-$6.01M	0.03%	409
2023 Q4	$108M	Sell	491,505 -21,876	-4%	-$5.04M	0.03%	380
2023 Q3	$116M	Buy	513,381 +36,801	+8%	+$8.48M	0.04%	344
2023 Q2	$105M	Buy	476,580 +14,316	+3%	+$3.17M	0.04%	372
2023 Q1	$104M	Sell	462,264 -23,024	-5%	-$5.68M	0.04%	357
2022 Q4	$135M	Sell	485,288 -25,106	-5%	-$6.34M	0.05%	309
2022 Q3	$107M	Buy	510,394 +6,420	+1%	+$1.44M	0.04%	355
2022 Q2	$119M	Sell	503,974 -54,258	-10%	-$11M	0.05%	338
2022 Q1	$102M	Sell	558,232 -36,966	-6%	-$7.04M	0.03%	415
2021 Q4	$129M	Sell	595,198 -46,146	-7%	-$9.06M	0.04%	377
2021 Q3	$118M	Sell	641,344 -29,799	-4%	-$5.87M	0.04%	394
2021 Q2	$120M	Sell	671,143 -8,667	-1%	-$1.65M	0.04%	421
2021 Q1	$114M	Sell	679,810 -28,835	-4%	-$4.81M	0.04%	423
2020 Q4	$108M	Sell	708,645 -21,235	-3%	-$2.79M	0.04%	408
2020 Q3	$73.7M	Sell	729,880 -40,956	-5%	-$4.49M	0.03%	453
2020 Q2	$93.3M	Sell	770,836 -5,577	-0.7%	-$628K	0.04%	384
2020 Q1	$73.6M	Buy	776,413 +255,101	+49%	+$24.2M	0.04%	385
2019 Q4	$45.9M	Buy	521,312 +83,815	+19%	+$7.38M	0.02%	716
2019 Q3	$34.9M	Buy	437,497 +239,056	+120%	+$19.3M	0.01%	839
2019 Q2	$15.5M	Buy	198,441 +193,777	+4,155%	+$18.1M	0.01%	1315
2019 Q1	$547K	Hold	4,664	–	–	﹤0.01%	816
2018 Q4	$508K	Hold	4,664	–	–	﹤0.01%	817
2018 Q3	$596K	Buy	4,664 +418	+10%	+$51.7K	﹤0.01%	835
2018 Q2	$480K	Hold	4,246	–	–	﹤0.01%	874
2018 Q1	$477K	Sell	4,246 -12,500	-75%	-$1.59M	﹤0.01%	899
2017 Q4	$2.48M	Buy	16,746 +12,500	+294%	+$1.59M	0.02%	567
2017 Q3	$498K	Sell	4,246 -46,904	-92%	-$5.99M	﹤0.01%	910
2017 Q2	$6.64M	Sell	51,150 -13,357	-21%	-$1.67M	0.04%	471
2017 Q1	$8.73M	Buy	64,507 +44,481	+222%	+$6.74M	0.05%	440
2016 Q4	$2.87M	Sell	20,026 -7,629	-28%	-$974K	0.01%	782
2016 Q3	$3.27M	Sell	27,655 -22,192	-45%	-$2.67M	0.02%	636
2016 Q2	$5.28M	Sell	49,847 -15,200	-23%	-$1.7M	0.03%	486
2016 Q1	$7.25K	Buy	65,047 +6,014	+10%	+$761K	0.04%	402
2015 Q4	$9.24K	Sell	59,033 -3,000	-5%	-$437K	0.05%	352
2015 Q3	$8.14K	Buy	62,033 +34,400	+124%	+$5.52M	0.05%	372
2015 Q2	$4.81K	Sell	27,633 -4,900	-15%	-$881K	0.03%	535
2015 Q1	$5.61M	Buy	32,533 +8,400	+35%	+$1.28M	0.03%	503
2014 Q4	$3.13M	Hold	24,133	–	–	0.02%	679
2014 Q3	$3.1M	Sell	24,133 -52	-0.2%	-$5.36K	0.02%	658
2014 Q2	$2.14M	Buy	24,185 +52	+0.2%	+$5K	0.01%	794
2014 Q1	$2.27M	Sell	24,133 -9,000	-27%	-$920K	0.01%	756
2013 Q4	$3.75M	Buy	33,133 +3,100	+10%	+$280K	0.02%	570
2013 Q3	$2.37M	Buy	30,033 +2,043	+7%	+$149K	0.02%	735
2013 Q2	$1.84M	Buy	+27,990	New	+$1.8M	0.01%	782